119th Congress · introduced in the Senate · May 22, 2025
Don’t Sell My DNA Act
Official title from Congress.gov
Latest action (May 22, 2025): Read twice and referred to the Committee on the Judiciary.
View on Congress.govPolicy area: Finance and Financial Sector
Congressional Research Service summary, version: Introduced in Senate (May 22, 2025)
Don’t Sell My DNA Act
This bill establishes protections for genetic information (e.g., information about an individual's genetic tests) in bankruptcy, particularly genetic information held by companies.
In bankruptcies, a trustee is appointed to arrange for the use, sale, or lease of property of the debtor’s estate. The bill provides that if the property of the estate includes genetic information, all affected persons—including those not involved in the bankruptcy—must consent in writing to the use, sale, or lease of the genetic information after the commencement of the bankruptcy case.
The trustee or debtor in a Chapter 11 (reorganization) bankruptcy must delete such genetic information if it is not disposed of in accordance with this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
12 citations.
CONSULI · lobbying firm or registrant: FRANKLIN SQUARE GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Banking
$50,000
Paid to lobbying firm
Issues related to bankruptcy and the sale of large data sets; H.R. 4492/S. 1916, Dont Sell My DNA Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ANCESTRY · lobbying firm or registrant: KELLEY DRYE & WARREN LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Bankruptcy
$30,000
Paid to lobbying firm
Dont Sell My DNA Act (S. 1916)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ANCESTRY · lobbying firm or registrant: KELLEY DRYE & WARREN LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Bankruptcy
$30,000
Paid to lobbying firm
Dont Sell My DNA Act (S. 1916)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CONSULI · lobbying firm or registrant: FRANKLIN SQUARE GROUP, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Banking
$50,000
Paid to lobbying firm
Issues related to bankruptcy and the sale of large data sets; H.R. 4492/S. 1916, Dont Sell My DNA Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CONSULI · lobbying firm or registrant: FRANKLIN SQUARE GROUP, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Banking
$50,000
Paid to lobbying firm
Issues related to bankruptcy and the sale of large data sets; H.R. 4492/S. 1916, Dont Sell My DNA Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ANCESTRY · lobbying firm or registrant: KELLEY DRYE & WARREN LLP
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Bankruptcy
$30,000
Paid to lobbying firm
Dont Sell My DNA Act (S. 1916)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CONSULI · lobbying firm or registrant: FRANKLIN SQUARE GROUP, LLC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Banking
$50,000
Paid to lobbying firm
Issues related to bankruptcy and the sale of large data sets; H.R. 4492/S. 1916, Dont Sell My DNA Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ANCESTRY · lobbying firm or registrant: KELLEY DRYE & WARREN LLP
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Bankruptcy
$30,000
Paid to lobbying firm
Dont Sell My DNA Act (S. 1916)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ANCESTRY · lobbying firm or registrant: KELLEY DRYE & WARREN LLP
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Bankruptcy
$30,000
Paid to lobbying firm
Dont Sell My DNA Act (S. 1916)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
COLLEGE OF AMERICAN PATHOLOGISTS · lobbying firm or registrant: COLLEGE OF AMERICAN PATHOLOGISTS
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 17, 2025 · issue area: Health Issues
$124,816
Spent on own lobbying
…illing Code Cost Act S 1830 - the Right to Treat Act S 1811 - Prohibits Graduate medical schools from receiving Federal assistance if DEI policies are in place S. 1916 - Protect Genetic information after bankruptcy S 1830 - HHS has no authority to regulate the practice of medicine S 2066, Medicare transaction Fraud prevention…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ANCESTRY · lobbying firm or registrant: KELLEY DRYE & WARREN LLP
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Bankruptcy
$30,000
Paid to lobbying firm
Dont Sell My DNA Act (S. 1916)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
COLLEGE OF AMERICAN PATHOLOGISTS · lobbying firm or registrant: COLLEGE OF AMERICAN PATHOLOGISTS
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 18, 2025 · issue area: Health Issues
$149,447
Spent on own lobbying
…illing Code Cost Act S 1830 - the Right to Treat Act S 1811 - Prohibits Graduate medical schools from receiving Federal assistance if DEI policies are in place S. 1916 - Protect Genetic information after bankruptcy S 1830 - HHS has no authority to regulate the practice of medicine S 2066, Medicare transaction Fraud prevention…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing